In 2008, SonoCiné AWBUS received FDA clearance as an adjunct to mammography– and was further validated by two peer-reviewed studies published in the journal, European Radiology in 2009 and 2010. The earlier of the two studies was recognized as the second-most cited paper that year, and has since been cited over 400 times. This paper concluded that SonoCiné AWBUS finds twice as many cancers as mammography alone, and three times as many small, invasive cancers (10mm or less).